ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Spherix Inc

Spherix Inc (SPEX)

1.63
0.00
(0.00%)
Closed January 25 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.63
Bid
1.56
Ask
1.58
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.63
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,345,000
Dividend Yield
-
PE Ratio
-0.38
Earnings Per Share (EPS)
-4.28
Revenue
2.04M
Net Profit
-22.88M

About Spherix Inc

Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

Sector
Security Brokers & Dealers
Industry
Security Brokers & Dealers
Headquarters
Wilmington, Delaware, USA
Founded
-

SPEX Latest News

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire NEW YORK, Feb. 3, 2021 NEW YORK, Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido...

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy Currently in Human Phase 2 Trials for Treatment of Prostate Cancer PR Newswire NEW YORK, Feb. 1, 2021 NEW YORK, Feb. 1, 2021...

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes...

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

BETHESDA, Md., Sept. 3 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces Positive Phase 2 Study Results

Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial. BETHESDA, Md., June 24 /PRNewswire-FirstCall/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SPEX - Frequently Asked Questions (FAQ)

What is the current Spherix share price?
The current share price of Spherix is $ 1.63
How many Spherix shares are in issue?
Spherix has 5,345,000 shares in issue
What is the market cap of Spherix?
The market capitalisation of Spherix is USD 8.71M
What is the 1 year trading range for Spherix share price?
Spherix has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Spherix?
The price to earnings ratio of Spherix is -0.38
What is the cash to sales ratio of Spherix?
The cash to sales ratio of Spherix is 4.27
What is the reporting currency for Spherix?
Spherix reports financial results in USD
What is the latest annual turnover for Spherix?
The latest annual turnover of Spherix is USD 2.04M
What is the latest annual profit for Spherix?
The latest annual profit of Spherix is USD -22.88M
What is the registered address of Spherix?
The registered address for Spherix is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Spherix website address?
The website address for Spherix is www.dominariholdings.com
Which industry sector does Spherix operate in?
Spherix operates in the SECURITY BROKERS & DEALERS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVNINVNI Group Ltd
$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
$ 90.11
(-38.07%)
8
ACONAclarion Inc
$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
$ 142.62
(-3.12%)
232.88M

Discussion

View Full Feed
Ex-brokerBry Ex-brokerBry 3 minutes ago
When you see trades going out 5 or 6 decibels it's usually the MM buying and selling between them.Nobody does anything for nothing now these days.This way a small gain is made on a menial basis.Another reason could be to hold the stock back from rising or falling.Won't be surprised if we see 20 cent
UMAV
Bull_Dolphin Bull_Dolphin 4 minutes ago
This one's for you stargazer kk:

https://x.com/AJamesMcCarthy/status/1882562974222799189
MartinLutherKing MartinLutherKing 4 minutes ago
The cure to cancer brother🚀🚀🚀
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary platform delivery system to defeat cancer, today announced a strategic expansion of its diverse product portfolio. Ne
RNAZ
Zorch305 Zorch305 5 minutes ago
the only thing seeming to Blow is Lumb by some accounts with him somehow involved continually I dont know the story line and not an insider with preferred but somebody was told something and raised the AS to 850 billion so its on whoever is the chairman
GNCP
weedtrader420 weedtrader420 7 minutes ago
Bitcoin is all set up for a big breakout $145k woohooooooooooo
BTCUSD
Hosai Hosai 9 minutes ago
"As I understand it OLE data is not considered to be very robust do to selection issues among others along with the open label compromise."

Which selection issue do you mean?

Normally an OLE is seen a less robust as no placebo control - you have to therefore compare aga
AVXL
sharkey1 sharkey1 11 minutes ago
Purdue makes lots of drugs,
From a quick search goog
What drugs does Purdue Pharma still make?
Purdue Pharma manufactures pain medicines such as hydromorphone, oxycodone, fentanyl, codeine, and hydrocodone. It makes drugs such as MS Contin, OxyContin, and Ryzolt. In 1972, Conti
ELTP
plexrec plexrec 11 minutes ago
Homer---" I truly believe we are on the cusp of transformational"--could you post a link where you found the quotes by this doctor ???? TIA Much appreciated !!!!
AVXL
100lbStriper 100lbStriper 11 minutes ago
forgot the thread link...... https://stocktwits.com/SilviaJ/message/601426100
NLST
Info3 Info3 14 minutes ago
I'll take religious prayers for .20 cents Alex 🙂
BMXI
europa7 europa7 14 minutes ago
SEALSQ Showcases World’s First PQC-Optimized Secure Hardware at Davos 2025
January 22, 2025
https://www.stocktitan.net/news/LAES/sealsq-showcases-world-s-first-pqc-optimized-secure-hardware-at-49eagr2kf0ax.html

"...SEALSQ Corp (NASDAQ: LAES) announced it will showcase th
LAES
steel8000 steel8000 17 minutes ago
Imo next week delfin / tglo will have news stay tuned ;)
TGLO
navycmdr navycmdr 19 minutes ago
A monster plan for homebuilding

It won’t emerge from the sea, but a planned monster-sized factory could shake up the nearly $5t housing market.

The company behind it, BOXABL, rewrote what’s possible in home construction with their patented assembly-line approach.
FNMA
jimr1717 jimr1717 19 minutes ago
Bingo! 🏆️ Post~Of~The~Week! 🏆️

“ Astonishingly, Sintx Technologies, despite 20 years of development and a complete absence of commercial revenue, has inexplicably failed to secure a single patent for its purportedly groundbreaking silicon nitride mater
SINT
MartinLutherKing MartinLutherKing 19 minutes ago
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary platform delivery system to defeat cancer, today announced a strategic expansion of its diverse product portfolio. New capabilities for TransCode’s TTX delivery platform are embo
RNAZ
microchips microchips 23 minutes ago
Stargate  ... So much money in this space. LWLG polymer will partner once the deals get structured. LWLG will be the tail on the dogs, and there are some big dogs out there. They didn't
LWLG
Bull_Dolphin Bull_Dolphin 25 minutes ago
Check out our local guy's handiwork:

https://winknews.com/2025/01/24/local-veteran-impresses-trump-and-stallone-with-handcrafted-flags/
NASDAQ2020 NASDAQ2020 26 minutes ago
HammerTime !
NVDA
JV44 JV44 27 minutes ago
And I can picture all 3 of those things as possibly happening in 2025... legit 5 -10 cents?...more? ..Go BC management.. GLTUA 🫡
MGON
jimr1717 jimr1717 29 minutes ago
Or perhaps they hired none and this is just another Fake It piece.
Anything to keep the public buying shares.
Just like the share buyback Pump.
It’s close to Two Buck Tuesday again.
No one is Fooled. Certainly not the institutions.
SINT
Robert31 Robert31 30 minutes ago
https://longportapp.com/en/news/225502699
SEV
trader53 trader53 32 minutes ago
WCVC - Can Do Things the RITE Way


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000

_______________________________________________________


WCVC - Most issuers will File a Form 10
https://investorshub.adv
RITE WCVC
jimr1717 jimr1717 33 minutes ago
🏆️ The Tesla Model Y 2024 has been awarded IIHS’s “top safety pick +” 🏆️ award from the Insurance Institute for Highway Safety (IIHS) despite more stringent eligibility..

https://electrek.co/2024/02/27/tesla-model-y-2024-scores-near-perfect-iihs-crash-tests/#:~:text=Th
TSLA
Bull_Dolphin Bull_Dolphin 33 minutes ago
Just got out of that cozy warm bed.... there are probably iguanas littering the landscape, but it's too danged cold to go out and check.

I don't get all you "Change of Seasons" folks. Cold weather sucks.

Your Recent History

Delayed Upgrade Clock